Costs and rehabilitation use of stroke survivors: a retrospective study of Medicare beneficiaries.
about
Nonhuman primate models of stroke for translational neuroprotection research.Modeling early-onset post-ischemic seizures in aging mice.Patient-level costs of major cardiovascular conditions: a review of the international literatureReview of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US.A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with HyperlipidemiaAxonal remodeling of the corticospinal tract in the spinal cord contributes to voluntary motor recovery after stroke in adult miceUpper-limb activity in adults: referent values using accelerometry.Translating promising preclinical neuroprotective therapies to human stroke trials.The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B protein in carotid surgery.Rehabilitation centers: marketing analysis and future challenges.An overview of robotic/mechanical devices for post-stroke thumb rehabilitation.Making if-then plans counteracts learned non-use in stroke patients: A proof-of-principle study.Neural stem cell-based therapy for ischemic stroke.Therapy Caps and Variation in Cost of Outpatient Occupational Therapy by Provider, Insurance Status, and Geographic Region.Comparison of the perioperative time courses of matrix metalloproteinase-9 (MMP-9) and its inhibitor (TIMP-1) during carotid artery stenting (CAS) and carotid endarterectomy (CEA)
P2860
Q26859430-657A28E4-945B-4298-91D4-2B31921F7CFFQ27311362-AE969082-EB45-41DE-A4AC-8757AD472420Q28076912-65A4EB5D-4917-447E-A85D-F8802BC4BAFAQ34680367-6ED83CDF-6AAD-4F8B-8334-7AE2C6DAA70CQ36327173-0367DC42-89EE-472B-B51C-9DE5F773948DQ37364039-C1801E2F-C4AE-4FED-87B0-C47D866BD050Q37526497-07383E65-DD1E-4B98-A774-838DAB34BB81Q37868574-9D01A278-FB6B-4DD6-9645-B4C8F04E3114Q38321172-3BA1846B-27EE-4D02-9BA2-177D5799D624Q38603996-CB394A82-45A0-4F2C-A10F-D1427C0630CAQ38874973-93B14503-F32D-43B6-B9ED-45D2B177FDD2Q39096786-7B593C83-56D6-4AB2-8E41-6DD7AE5CCC22Q48243604-EF3F4EBB-A9A1-4ABA-85E0-285F720BC113Q48639079-291F9461-1665-49A3-B67A-047FDC0DBD13Q48926171-4BEAE1F3-AC84-4EBD-928B-58895A9CEFDCQ50050732-9C526AD7-FD21-403E-AA44-07DDCB943D94Q58695988-518E901E-93EA-43C0-8BB3-176863855489
P2860
Costs and rehabilitation use of stroke survivors: a retrospective study of Medicare beneficiaries.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Costs and rehabilitation use o ...... udy of Medicare beneficiaries.
@en
Costs and rehabilitation use o ...... udy of Medicare beneficiaries.
@nl
type
label
Costs and rehabilitation use o ...... udy of Medicare beneficiaries.
@en
Costs and rehabilitation use o ...... udy of Medicare beneficiaries.
@nl
prefLabel
Costs and rehabilitation use o ...... udy of Medicare beneficiaries.
@en
Costs and rehabilitation use o ...... udy of Medicare beneficiaries.
@nl
P2093
P2860
P356
P1476
Costs and rehabilitation use o ...... udy of Medicare beneficiaries.
@en
P2093
Kuo Bianchini Tong
Marianne Laouri
Richard D Zorowitz
P2860
P304
P356
10.1310/TSR1605-309
P577
2009-09-01T00:00:00Z